Metformin × glycemic control

TrialCardiovascular diabetology2017

Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial.

Syed Wasif Gillani et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 2017

Randomised comparison

Probably raised glycemic control

2.3×1.9× to 4.4×

Bigger than 6 in 10 for glycemic control

As reported

OR 2.31, 95% CI 1.87–4.42

One number in the abstract

the abstract, start to end

alone (control arm) in a year (OR 2.31 (95% CI 1.87-4.42) p < 0.001).

← favours treatmentfavours comparator →
could be chance
Glycemic control
OR 2.311.87–4.42
MetforminGlycemic control

Metformin × glycemic controlhelps?replicated

unlikelylikely
0.840.86 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

22 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28807030